Daniel Joseph OConnell - 30 Nov 2021 Form 4 Insider Report for Acumen Pharmaceuticals, Inc. (ABOS)

Role
President and CEO, Director
Signature
/s/ Katie Lapidus, Attorney-in-Fact
Issuer symbol
ABOS
Transactions as of
30 Nov 2021
Net transactions value
+$4,997
Form type
4
Filing time
02 Dec 2021, 15:41:28 UTC
Previous filing
08 Jul 2021
Next filing
21 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABOS Common Stock Options Exercise $4,997 +1,118 +71% $4.47 2,685 30 Nov 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABOS Stock Option (Right to Buy) Options Exercise $0 -1,118 -100% $0.000000* 0 30 Nov 2021 Common Stock 1,118 $4.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Immediately exercisable.